As of Oct 02
| +1.68 / +2.26%|
The 6 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 103.50, with a high estimate of 132.00 and a low estimate of 84.00. The median estimate represents a +36.02% increase from the last price of 76.09.
The current consensus among 9 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.